Is Viloxazine safe while breastfeeding?
Here is what NIH LactMed, the U.S. National Library of Medicine's authority on medicines and breastfeeding, reports about Viloxazine. This is a summary of that source — not our own verdict.
Effects on the breastfed infant
Relevant published information was not found as of the revision date.
Effects on milk supply
Relevant published information was not found as of the revision date.
Levels in milk
Maternal Levels. The manufacturer reports a study in 15 lactating women took viloxazine 600 mg daily for 3 days. The mean total amounts of viloxazine and its metabolite, 5-HVLX-gluc excreted in 24 hours at steady-state were 0.511 mg and 0.0357 mg, or 0.085 mg/kg and 0.00595 mg/kg, respectively in a 6 kg infant. These amounts were estimated to result in a relative infant dose of 1% and 0.07%, respectively. Infant Levels. Relevant published information was not found as of the revision date.
Alternatives LactMed lists
“No published information” means the studies do not exist yet — not that Viloxazine is known to be harmful, and not that it is known to be safe. Your prescriber or pharmacist can weigh your baby's age and whether a better-studied alternative would do the same job. Worth asking before stopping a medicine you need.
Source: NIH LactMed (National Library of Medicine).
Educational summary of an authoritative source — not medical advice. Never start, stop, or change a medicine while breastfeeding without confirming with your doctor.